MolecuLight Featured in 11 Presentations and Posters at European Wound Management Association (EWMA) 2024 Annual Conference

May 2, 2024 -Wide-Spread Clinical Evidence using the MolecuLight Imaging Platform Reveals its Significant Global Adoption and Proven Utility in Wound Care

Toronto, CANADA and London, UK – (May 1, 2024) – MolecuLight Corp., the leader in point-of-care digital wound measurement and real-time bacterial detection through fluorescence imaging, announces that its MolecuLight wound imaging

Read More

MolecuLight Awarded Federal Supply Contract for the US Department of Veterans Affairs

January 25, 2024 -New Contract Expands VA Wound Care Center Access to MolecuLight i:X® and DX™ Point-of-Care Devices that Help Clinicians Manage Infection and Improve Outcomes

Pittsburgh, PA – January25, 2024 – MolecuLight Corp., the leader in point-of-care bacterial fluorescence imaging, announced today that the US Department of Veterans Affairs has awarded MolecuLight a

Read More

MolecuLight Successfully Completes SOC 2 Type II Audit

December 12, 2023 -The company’s compliance to SOC 2 Type II demonstrates the suitability of the design and operating effectiveness of its controls relevant to security

TORONTO, ON – (December 12, 2023) MolecuLight Inc., the leader in point-of-care fluorescence imaging that locates and detects elevated bacterial loads in and around wounds, announces

Read More

Latest Clinical Evidence Presented at APWCA’s Wound Week™ 2023 Illustrates the Significant and New Clinical Utility

September 21, 2023 -6 Clinical Posters and a Presentation Including New Results of a 1,447 Patient Study Highlights the Breadth of Clinical Benefits of the MolecuLight Device for Wound Care Applications

Toronto, ONTARIO and Philadelphia, PENNSYLVANIA – (September 21, 2023) MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of

Read More

Largest Published Real-World Wound Imaging Study Reports MolecuLight® led to Wound Treatment Plan Changes in up to 53% Cases

May 23, 2023 -Results from 211 Facilities Show MolecuLight Imaging is a Valuable Tool in Improving Bacterial Infection Management

TORONTO, ON – (May 23, 2023) MolecuLight Inc., the leader in point-of-care fluorescence imaging that locates and detects elevated, pathogenic bacterial loads in and around wounds, announced the publication of their latest publication,

Read More

Previous